Literature DB >> 21887477

Suppression of Th17 response by Streptococcus thermophilus ST28 through induction of IFN-γ.

Tasuku Ogita1, Yusuke Tanii, Hidetoshi Morita, Takuya Suzuki, Soichi Tanabe.   

Abstract

The proinflammatory cytokine interleukin (IL)-17 plays important roles in various inflammatory diseases, and IL-17-producing T helper 17 cells (Th17) have received much attention. For therapy of Th17-mediated diseases, some reports have indicated the clinical efficacy of lactic acid bacteria, including Streptococcus thermophilus. In this study, we examined the mechanism for the suppressive effects of S. thermophilus ST28 on the Th17 response in murine splenocytes stimulated with transforming growth factor (TGF)-β plus IL-6. Stimulation with TGF-β plus IL-6 increased mRNA expression of IL-17 and its production in the splenocytes, but ST28 markedly suppressed both. Meanwhile, ST28 increased the mRNA expression of interferon (IFN)-γ as well as its production. Anti-IFN-γ completely cancelled the suppressive effect of ST28 on IL-17 production. From these data, it was concluded that IFN-γ induced by ST28 had an important role on the effect. A genomic DNA (10 µg/ml) from ST28 effectively suppressed IL-17 production, probably via the Toll-like receptor 9. Therefore, modulation of Th1/Th17 balance would be one of the mechanisms under which S. thermophilus ST28 exerts an anti-inflammatory effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887477     DOI: 10.3892/ijmm.2011.755

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells.

Authors:  Tasuku Ogita; Megumi Nakashima; Hidetoshi Morita; Yasuo Saito; Takuya Suzuki; Soichi Tanabe
Journal:  J Biomed Biotechnol       Date:  2011-10-12

Review 3.  Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.

Authors:  Suguru Shigemori; Takeshi Shimosato
Journal:  Front Immunol       Date:  2017-01-25       Impact factor: 7.561

4.  Anti-inflammatory and Intestinal Barrier-protective Activities of Commensal Lactobacilli and Bifidobacteria in Thoroughbreds: Role of Probiotics in Diarrhea Prevention in Neonatal Thoroughbreds.

Authors:  Soichi Tanabe; Takuya Suzuki; Yuichiro Wasano; Fumihiko Nakajima; Hiroshi Kawasaki; Tomonori Tsuda; Natsuko Nagamine; Takashi Tsurumachi; Kiyoshi Sugaya; Hiroaki Akita; Misako Takagi; Kunihiko Takagi; Yoshinobu Inoue; Yo Asai; Hidetoshi Morita
Journal:  J Equine Sci       Date:  2014-06-25

Review 5.  Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

Authors:  Eddy Owaga; Rong-Hong Hsieh; Beatrice Mugendi; Sakhile Masuku; Chun-Kuang Shih; Jung-Su Chang
Journal:  Int J Mol Sci       Date:  2015-09-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.